D
Denali Therapeutics Inc. DNLI
$15.49 $0.261.71% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -124.12M -132.97M -114.75M -107.19M -99.03M
Total Depreciation and Amortization 3.96M 3.21M -5.28M 2.27M 1.94M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 21.58M 20.22M 25.76M 15.43M 14.02M
Change in Net Operating Assets 23.29M -21.93M 10.56M 30.35M -8.16M
Cash from Operations -75.30M -131.47M -83.72M -59.14M -91.22M
Capital Expenditure -4.28M -5.08M -5.09M -3.88M -4.79M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 162.21M 23.83M 177.30M 97.54M 103.36M
Cash from Investing 157.94M 18.75M 172.21M 93.66M 98.57M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -2.43M -4.36M -8.32M -24.02M --
Issuance of Common Stock 4.06M 595.00K 4.16M 5.94M 6.76M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- 0.00 -480.00K 0.00
Cash from Financing 1.62M -3.76M -4.17M -18.56M 6.76M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 84.26M -116.48M 84.32M 15.96M 14.11M